Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.7469
+0.0419 (5.94%)
Aug 11, 2026, 3:16 PM EDT - Market open
Envoy Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19.68 | 3.74 | 5.48 | 4.22 | 0.18 | 0.15 |
Cash & Short-Term Investments | 19.68 | 3.74 | 5.48 | 4.22 | 0.18 | 0.15 |
Cash Growth | 272.22% | -31.81% | 29.99% | 2204.92% | 22.13% | - |
Accounts Receivable | 0.05 | 0.03 | 0.04 | 0.07 | 0.04 | - |
Other Receivables | 0.02 | 0.02 | 0.78 | 0.18 | - | - |
Total Trade Receivables | 0.07 | 0.05 | 0.82 | 0.25 | 0.04 | - |
Inventory | 1.58 | 1.55 | 1.71 | 1.4 | 1.3 | - |
Other Current Assets | 0.59 | 0.94 | 0.89 | 1.59 | 0.13 | 1.72 |
Total Current Assets | 21.92 | 6.28 | 8.9 | 7.46 | 1.65 | 0.86 |
Net Property, Plant & Equipment | 1.74 | 1.92 | 2.15 | 0.82 | 0.91 | - |
Long-Term Investments | - | - | - | - | - | 425.04 |
Other Long-Term Assets | 0.29 | 0.36 | 0.49 | - | - | - |
Total Assets | 23.95 | 8.56 | 11.54 | 8.27 | 2.56 | 426.9 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.04 | 2.92 | 1.65 | 1.55 | 1 | 0.62 |
Accrued Expenses | 10.03 | 7.64 | 4.42 | 4.61 | 0.61 | 2.06 |
Current Portion of Long-Term Debt | - | - | - | - | 0.45 | - |
Current Portion of Leases | 0.13 | 0.17 | 0.14 | 0.16 | 0.13 | - |
Other Current Liabilities | 0.44 | 0.83 | 1.33 | 0.96 | 0.34 | - |
Total Current Liabilities | 12.63 | 11.56 | 7.54 | 7.29 | 2.52 | 2.68 |
Long-Term Debt | - | - | 18.72 | - | 33.4 | - |
Long-Term Leases | 0.68 | 0.75 | 0.8 | 0.4 | 0.57 | - |
Other Long-Term Liabilities | 6.94 | 8.02 | 3.32 | 2.36 | 2.27 | 35.94 |
Total Long-Term Liabilities | 7.62 | 8.76 | 22.84 | 2.76 | 36.23 | 35.94 |
Total Liabilities | 20.26 | 20.33 | 30.38 | 10.05 | 38.75 | 38.62 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | 329.79 | 301.36 | 266.01 | 255.6 | 189.9 | - |
Accumulated Other Comprehensive Income | -0.12 | -0.12 | -0.12 | -0.12 | -0.12 | - |
Retained Earnings | -326.37 | -313.4 | -284.73 | -257.26 | -225.99 | -36.71 |
Total Common Shareholders' Equity | 3.3 | -12.16 | -18.84 | -1.78 | -36.2 | -36.71 |
Minority Interest | 0.39 | 0.39 | - | - | - | 425 |
Shareholders' Equity | 3.69 | -11.77 | -18.84 | -1.78 | -36.2 | 388.29 |
Total Liabilities & Equity | 23.95 | 8.56 | 11.54 | 8.27 | 2.56 | 426.9 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.81 | 0.92 | 19.66 | 0.56 | 34.54 | 0 |
Net Cash (Debt) | 18.87 | 2.82 | -14.18 | 3.66 | -34.35 | 0.15 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 0.34 | 0.12 | -0.76 | 0.30 | -3.39 | 0.01 |
Book Value | 3.3 | -12.16 | -18.84 | -1.78 | -36.2 | -36.71 |
Book Value Per Share | 0.06 | -0.52 | -1.00 | -0.14 | -3.58 | -3.63 |
Tangible Book Value | 3.3 | -12.16 | -18.84 | -1.78 | -36.2 | -36.71 |
Tangible Book Value Per Share | 0.06 | -0.52 | -1.00 | -0.14 | -3.58 | -3.63 |